Roche receives positive CHMP opinion for Tecentriq as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer

Recommendation is based on the Phase III IMpower110 study showing that Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy If approved, Tecentriq could offer people with a specific type of lung cancer a chemotherapy-free option in the first-line treatment setting Basel, 26 March 2021 – Roche (SIX: RO, ROG;... Read more

Danaher Schedules First Quarter 2021 Earnings Conference Call

WASHINGTON, March 25, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2021 on Thursday, April 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more

Illumina Announces Board Changes

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) (the “Company”) today announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These changes will be effective as of the Company’s Annual Shareholder Meeting on May 26, 2021. This... Read more

Bio-Techne Announces ISO 9001:2015 Certification for Its Bristol Manufacturing Facility.

MARCH 15, 2021 MINNEAPOLIS, March 15, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that its Bristol site in the United Kingdom received ISO 9001:2015 Quality Management Systems certification. Bio-Techne’s Bristol facility produces life science reagents for... Read more

Roche’s awarded WHO prequalification for the HIV and HCV diagnostic tests on the cobas 6800/8800 Systems

For patients living in areas with limited healthcare resources, WHO prequalification ensures access to the highest quality diagnostics Access to broader reliable diagnostic solutions helps healthcare communities working to expedite and increase disease elimination programs Roche’s Global Access Program provides innovative diagnostic solutions improving disease and patient management for those most in need Basel, 11... Read more

Thermo Fisher Scientific Investments Support Rapidly Increasing Bioprocessing Production

Thermo Fisher Scientific Investments Support Rapidly Increasing Bioprocessing Production More than $600 million in investments will enable reliable supply of critical materials used to produce new vaccines and biologics WALTHAM, Mass., March 10, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced more than $600 million in capital... Read more

Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer

SANTA CLARA, Calif., March 09, 2021  Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company’s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company’s presence in the health-care industry. As Agilent’s first... Read more

10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations

City to Change Street Name to ‘Genomics Place’ PLEASANTON, Calif., March 09, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced expansion plans to support the company’s continued growth in Pleasanton across two properties. Along with the leasing of a second building in the same complex as its current headquarters, 10x has acquired the... Read more

Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2 Mar 04, 2021 6:30 AM EST Provides labs with high throughput, syndromic respiratory testing capabilities AUSTIN, Texas, March 4, 2021... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of Pacific Biosciences common stock... Read more